(19)
(11) EP 1 185 261 A1

(12)

(43) Date of publication:
13.03.2002 Bulletin 2002/11

(21) Application number: 00942843.4

(22) Date of filing: 15.06.2000
(51) International Patent Classification (IPC)7A61K 31/27
(86) International application number:
PCT/US0016/499
(87) International publication number:
WO 0076/495 (21.12.2000 Gazette 2000/51)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 16.06.1999 US 139675 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19103 (US)

(72) Inventors:
  • BENSON, Gregory, Martin
    Harlow,Essex CM19 5AW (GB)
  • HERTZBERG, Robert, P.
    Downingtown, PA 19335 (US)
  • JUREWICZ, Anthony, J.
    Royersford, PA 19468 (US)
  • RUTLEDGE, Melvin, Clarence
    Andubon, PA 19403 (US)
  • VEBER, Daniel, F.
    Ambler, PA 19002 (US)
  • WIDDOWSON, Katherine, L.
    King of Prussia, PA 19406 (US)

(74) Representative: Blakey, Alison Jane 
GlaxoSmithKlineCorporate Intellectual PropertyTwo New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) IL-8 RECEPTOR ANTAGONISTS